# The Prevention and Treatment of Nausea Associated With Motion Sickness

> **NCT03986905** · PHASE3 · COMPLETED · sponsor: **Repurposed Therapeutics, Inc.** · enrollment: 300 (actual)

## Conditions studied

- Motion Sickness

## Interventions

- **DRUG:** Scopolamine Nasal Gel
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03986905
- **Lead sponsor:** Repurposed Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-26
- **Primary completion:** 2019-05-19
- **Final completion:** 2019-06-19
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2019-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03986905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03986905, "The Prevention and Treatment of Nausea Associated With Motion Sickness". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03986905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*